triamcinolone acetonide has been researched along with Desmoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attia, S; Bestic, JM; Chase, LA; Garner, HW; Heckman, MG; Schoch, JJ; Wilke, BK | 1 |
| Arpornchayanon, O; Chaiyawat, P; Klangjorhor, J; Kosachunhanun, N; Lorsomradee, S; Phanphaisarn, A; Pruksakorn, D; Settakorn, J; Teeyakasem, P | 1 |
1 trial(s) available for triamcinolone acetonide and Desmoid
| Article | Year |
|---|---|
Safety and efficacy of intralesional steroid injection for aggressive fibromatosis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cushing Syndrome; Dermatologic Surgical Procedures; Dose-Response Relationship, Drug; Female; Fibromatosis, Aggressive; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Injections, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Ultrasonography, Interventional; Young Adult | 2017 |
1 other study(ies) available for triamcinolone acetonide and Desmoid
| Article | Year |
|---|---|
A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two-Year Outcomes.
Topics: Fibromatosis, Aggressive; Glucocorticoids; Humans; Injections, Intralesional; Pilot Projects; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide | 2023 |